Table 1.
Structure | Advantages | Limitations | References |
---|---|---|---|
Cortical model based on 3D hydrogel gel (neurons and astrocytes) | • Deposition of amyloid plaques | • Absence of vascular cells | Choi et al. (2014); Kim et al. (2015b); Jorfi et al. (2018) |
• Accumulation of pTau | • Absence of flow | ||
• High-throughput possible | • Cell lines with FAD mutations | ||
• Short time of culture | |||
Cortical model based on 3D hydrogel gel (neurons, astrocyte and microglia) | • Deposition of amyloid plaques | • Absence of vascular cells | Park et al. (2018) |
• Accumulation of pTau | • Absence of flow | ||
• Microglial migration assay | • Cell lines | ||
• Short time of culture | |||
NVU capillary model based on microfluidic chip (EC, astrocytes and neurons) | • CAA and amyloid plaque deposition | • Cell lines | Shin et al. (2019) |
• Live imaging | • Absence of mural cells | ||
• Vascular flow | • Non-contractile | ||
• EC permeability assays | |||
• Short time of culture | |||
Cortical model based on organoids (neurons and astrocytes) | • IPSC from AD patient | • Low through put | Lee et al. (2016); Gonzalez et al. (2018) |
• Deposition of amyloid plaques | • Long time of culture | ||
• Accumulation of pTau | • Absence of vascular cells | ||
• Apoptosis assay | • Absence of flow | ||
Capillary model based on 3D hydrogel (EC, pericytes and astrocytes) | • IPSC from patient | • No perfusion | Blanchard et al. (2020) |
• CAA | • Exogenous Ab | ||
• Deposition of BM | • Absence of neuron | ||
• Self-organization of the vasculature | • Non-contractile? | ||
• Short time of culture | |||
Arterial model based on tissue engineering (EC, SMC and astrocytes) | • CAA | • Recombinant Ab | Robert et al. (2017) |
• Vascular flow | • Absence of neuron | ||
• Trans-endothelial transport | • Low throughput | ||
• Primary cells | • Long time of culture | ||
• Monocyte perfusion | • Non-contractile | ||
• Live media sampling in lumen and ablumen | |||
NVU arterial model based on tissue engineering (EC, SMC, astrocytes and neurons) | • CAA | • Low throughput | Robert et al. (2020) |
• Accumulation of pTau | • Long time of culture | ||
• Neuronal and glial biomarkers | • Non-contractile | ||
• Trans-endothelial transport | • Umbilical origin of the vascular cells | ||
• Vascular flow | |||
• Live media sampling in lumen and ablumen |
3D: Three-dimensional; AD: Alzheimer’s disease; Aβ: amyloid beta; BM: basement membrane; CAA: cerebral amyloid angiopathy; EC: endothelial cells; FAD: early onset familial AD; IPSC: induced pluripotent stem cells; NVU: neurovascular unit; pTau: phosphorylated Tau; SMC: smooth-muscle cells.